- cafead   May 16, 2024 at 11:42: AM
via Oxford BioDynamics (OBD) and King's College London (KCL) have partnered to use OBD's EpiSwitch technology to identify patients at risk of rheumatoid arthritis (RA) who can benefit from abatacept treatment.
article source
article source